Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on July 14, 2026

GPX® Embolic Device meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
CommerceShop to Host Free Webinar on Winning in Agentic Commerce for Mid-Market and B2B Brands
Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner
Exoskeleton Market to Reach USD 2.35 Billion by 2031 as Wearable Robotics Adoption Grows, Says Mordor Intelligence
Visory Health gana un Digital Health Award por segundo año consecutivo
Burial Insurance Market Size & Growth: USD 326.49 Bn in 2026, USD 463.13 Bn by 2033 at 6.0% CAGR | Transamerica
Adrienne Wilkerson of Beacon Media + Marketing to Speak at Recovery.com Marketing Summit in Madison, WI
Synkriom Awarded GoodBuy Contract to Support Educational Facilities Across Texas
US Navy Veterans Mesothelioma & Lung Cancer Advocate Urges a Navy Veteran with Lung Cancer or Mesothelioma to Call About Better Compensation Results and Direct Access to the Nation's Top Lawyers-Get Compensated
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy
Tokyo-Based 'Zenkyu Matcha' Expands in London with Exclusive Workshop at British Sustainable Fashion Label 'Story mfg.'
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
AVITA Medical to Announce Second Quarter 2026 Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.